ANAB Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 33.70%

Insider Buying (Last 12 Months): $10,928,220.98

Insider Selling (Last 12 Months): $1,377,759.10

AnaptysBio Insider Trading History Chart

AnaptysBio Share Price & Price History

^$18.95

▲ +0.3 (1.61%)

As of 03/28/2025 05:00 PM ET

Days: 30 | 90 | 365

AnaptysBio Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/2/2025	Ecor1 Capital, Llc	Director	Buy	6,646	$12.95	$86,065.70	7,880,094
12/30/2024	Ecor1 Capital, Llc	Director	Buy	65,184	$12.92	$842,177.28	7,860,180
9/23/2024	Paul F Lizzul	Insider	Sell	1,500	$38.67	$58,005.00	15,398
9/16/2024	Dennis Mulroy	CFO	Sell	12,220	$39.91	$487,700.20	4,744
9/16/2024	Eric J. Loumeau	Insider	Sell	8,720	$39.82	$347,230.40	7,020
8/14/2024	Ecor1 Capital, Llc	Major Shareholder	Buy	273,972	$36.50	$9,999,978.00	7,794,996
7/18/2024	Paul F Lizzul	Insider	Sell	1,500	$35.00	$52,500.00	11,618
7/15/2024	Hollings Renton	Director	Sell	10,000	$30.64	$306,400.00	1,950
6/21/2024	Dennis M Fenton	Director	Sell	1,950	$23.17	$45,181.50	1,950
6/18/2024	Hollings Renton	Director	Sell	1,950	$23.16	$45,162.00	1,950
5/22/2024	Dennis Mulroy	CFO	Sell	1,500	$23.72	$35,580.00	964
3/25/2024	Daniel Faga	CEO	Sell	3,000	$21.42	$64,260.00	749,087
3/22/2024	Daniel Faga	CEO	Sell	145,940	$22.78	$3,324,513.20	752,087
2/16/2024	Eric J. Loumeau	Insider	Sell	5,000	$25.00	$125,000.00	3,240
1/30/2024	Dennis Mulroy	CFO	Sell	3,065	$23.63	$72,425.95	964
1/8/2024	Daniel Faga	CEO	Sell	6,866	$21.81	$149,747.46	898,027
1/8/2024	Dennis Mulroy	CFO	Sell	2,180	$21.81	$47,545.80	4,029
1/8/2024	Paul F Lizzul	Insider	Sell	2,554	$21.81	$55,702.74	10,118
11/22/2023	Eric J. Loumeau	Insider	Sell	882	$14.19	$12,515.58
9/18/2023	Eric J. Loumeau	Insider	Sell	3,895	$19.32	$75,251.40	882
9/14/2023	Paul F Lizzul	Insider	Sell	2,105	$19.48	$41,005.40	6,527
6/8/2022	Eric J. Loumeau	COO	Sell	2,500	$24.00	$60,000.00	523
5/18/2022	Eric J. Loumeau	COO	Sell	1,146	$20.50	$23,493.00	523
5/5/2022	Ecor1 Capital, Llc	Major Shareholder	Buy	668,237	$21.63	$14,453,966.31	7,521,024

See Full Table

SEC Filings (Institutional Ownership Changes) for AnaptysBio (NASDAQ:ANAB)

Institutional Buying and Selling by Quarter

AnaptysBio Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	66,467	$0.88M	0.0%	+0.8%	0.217%
3/18/2025	California State Teachers Retirement System	14,590	$0.19M	0.0%	+10.3%	0.048%
2/18/2025	Frazier Life Sciences Management L.P.	1,573,719	$20.84M	0.9%	-28.8%	5.172%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	29,479	$0.39M	0.0%	-10.4%	0.097%
2/17/2025	Voloridge Investment Management LLC	87,513	$1.16M	0.0%	-49.5%	0.288%
2/17/2025	Woodline Partners LP	485,073	$6.42M	0.0%	+5.5%	1.594%
2/17/2025	Soleus Capital Management L.P.	414,000	$5.48M	0.3%	N/A	1.360%
2/17/2025	Squarepoint Ops LLC	80,870	$1.07M	0.0%	+81.7%	0.266%
2/17/2025	Two Sigma Advisers LP	293,300	$3.88M	0.0%	+58.1%	0.964%
2/17/2025	Two Sigma Investments LP	352,034	$4.66M	0.0%	+66.4%	1.157%
2/17/2025	Sanofi	821,917	$10.88M	6.2%	N/A	2.701%
2/17/2025	Rafferty Asset Management LLC	70,883	$0.94M	0.0%	+83.2%	0.233%
2/17/2025	Millennium Management LLC	146,517	$1.94M	0.0%	-55.8%	0.481%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	15,012	$0.20M	0.0%	+21.9%	0.049%
2/17/2025	Jacobs Levy Equity Management Inc.	85,381	$1.13M	0.0%	+85.3%	0.281%
2/17/2025	Graham Capital Management L.P.	18,954	$0.25M	0.0%	N/A	0.062%
2/17/2025	Granahan Investment Management LLC	106,079	$1.40M	0.1%	N/A	0.349%
2/17/2025	Ensign Peak Advisors Inc	215,454	$2.85M	0.0%	+184.4%	0.708%
2/17/2025	Fairmount Funds Management LLC	1,816,466	$24.05M	2.4%	N/A	5.969%
2/17/2025	Deutsche Bank AG	17,867	$0.24M	0.0%	+52.0%	0.059%
2/17/2025	D. E. Shaw & Co. Inc.	197,107	$2.61M	0.0%	-12.1%	0.648%
2/17/2025	Bridgefront Capital LLC	19,011	$0.25M	0.1%	N/A	0.062%
2/17/2025	Bank of America Corp DE	17,949	$0.24M	0.0%	-89.2%	0.059%
2/17/2025	BNP Paribas Financial Markets	23,126	$0.31M	0.0%	-65.0%	0.076%
2/14/2025	Boxer Capital Management LLC	1,300,000	$17.21M	1.5%	N/A	4.272%
2/14/2025	First Light Asset Management LLC	868,882	$11.50M	1.1%	-8.4%	2.855%
2/14/2025	Northern Trust Corp	219,986	$2.91M	0.0%	+10.0%	0.723%
2/14/2025	The Manufacturers Life Insurance Company	36,452	$0.48M	0.0%	-13.3%	0.120%
2/14/2025	Susquehanna Fundamental Investments LLC	44,785	$0.59M	0.0%	N/A	0.147%
2/14/2025	Virtus ETF Advisers LLC	4,733	$63K	0.0%	+24.7%	0.016%
2/14/2025	Nebula Research & Development LLC	17,422	$0.23M	0.0%	N/A	0.057%
2/14/2025	Price T Rowe Associates Inc. MD	925,007	$12.25M	0.0%	+0.2%	3.040%
2/14/2025	Tower Research Capital LLC TRC	2,697	$36K	0.0%	+131.3%	0.009%
2/14/2025	Dimensional Fund Advisors LP	31,608	$0.42M	0.0%	-67.1%	0.104%
2/13/2025	XTX Topco Ltd	40,013	$0.53M	0.0%	+97.2%	0.131%
2/13/2025	Barclays PLC	83,567	$1.11M	0.0%	+88.6%	0.275%
2/13/2025	Renaissance Technologies LLC	193,200	$2.56M	0.0%	-3.6%	0.635%
2/13/2025	Invesco Ltd.	23,288	$0.31M	0.0%	-54.6%	0.077%
2/13/2025	ADAR1 Capital Management LLC	27,301	$0.36M	0.1%	-85.8%	0.090%
2/13/2025	Federated Hermes Inc.	45,184	$0.60M	0.0%	-85.8%	0.148%
2/13/2025	Aristides Capital LLC	12,700	$0.17M	0.0%	N/A	0.042%
2/13/2025	Russell Investments Group Ltd.	5,698	$75K	0.0%	+1,585.8%	0.019%
2/13/2025	Wells Fargo & Company MN	11,120	$0.15M	0.0%	-59.0%	0.037%
2/12/2025	Trexquant Investment LP	60,720	$0.80M	0.0%	-38.0%	0.200%
2/12/2025	Geode Capital Management LLC	486,597	$6.44M	0.0%	+4.6%	1.599%
2/12/2025	JPMorgan Chase & Co.	114,939	$1.52M	0.0%	+240.6%	0.378%
2/11/2025	Vanguard Group Inc.	1,843,740	$24.41M	0.0%	+8.4%	6.059%
2/11/2025	KLP Kapitalforvaltning AS	3,000	$40K	0.0%	N/A	0.010%
2/10/2025	Swiss National Bank	29,700	$0.39M	0.0%	+12.1%	0.098%
2/7/2025	AlphaQuest LLC	4,461	$59K	0.0%	+1,891.5%	0.015%
2/6/2025	Victory Capital Management Inc.	334,450	$4.43M	0.0%	+41.0%	1.099%
2/6/2025	Charles Schwab Investment Management Inc.	166,054	$2.20M	0.0%	+3.6%	0.546%
2/5/2025	Fisher Asset Management LLC	58,878	$0.78M	0.0%	-5.0%	0.193%
2/4/2025	Bank of New York Mellon Corp	57,169	$0.76M	0.0%	-3.3%	0.188%
2/4/2025	Y Intercept Hong Kong Ltd	23,497	$0.31M	0.0%	N/A	0.077%
1/30/2025	Rhumbline Advisers	30,077	$0.40M	0.0%	+3.8%	0.099%
1/24/2025	Jennison Associates LLC	269,131	$3.56M	0.0%	+1.6%	0.884%
1/24/2025	China Universal Asset Management Co. Ltd.	6,452	$85K	0.0%	+11.1%	0.021%
1/17/2025	SG Americas Securities LLC	16,307	$0.22M	0.0%	+35.0%	0.054%
1/14/2025	Assenagon Asset Management S.A.	331,758	$4.39M	0.0%	-30.2%	1.090%
12/26/2024	JPMorgan Chase & Co.	33,744	$1.13M	0.0%	+191.4%	0.111%
11/27/2024	Franklin Resources Inc.	354,370	$12.31M	0.0%	-23.9%	1.165%
11/19/2024	Barclays PLC	44,300	$1.49M	0.0%	+117.4%	0.146%
11/16/2024	Geode Capital Management LLC	465,401	$15.59M	0.0%	+3.0%	1.529%
11/15/2024	Frazier Life Sciences Management L.P.	2,209,189	$74.01M	3.0%	+2.0%	7.260%
11/15/2024	Barclays PLC	44,300	$1.49M	0.0%	+117.4%	0.146%
11/15/2024	XTX Topco Ltd	20,286	$0.68M	0.0%	+49.1%	0.067%
11/15/2024	Wellington Management Group LLP	65,939	$2.21M	0.0%	+4.8%	0.217%
11/15/2024	State Street Corp	906,182	$30.36M	0.0%	-6.3%	2.978%
11/15/2024	Point72 DIFC Ltd	6,127	$0.21M	0.0%	+680.5%	0.020%
11/15/2024	Point72 Asset Management L.P.	54,200	$1.82M	0.0%	+202.8%	0.178%
11/15/2024	Parkman Healthcare Partners LLC	138,100	$4.63M	0.6%	-46.1%	0.454%
11/15/2024	Jacobs Levy Equity Management Inc.	46,074	$1.54M	0.0%	-2.4%	0.151%
11/15/2024	Janus Henderson Group PLC	7,464	$0.25M	0.0%	N/A	0.025%
11/15/2024	HighVista Strategies LLC	15,574	$0.52M	0.2%	N/A	0.051%
11/14/2024	PDT Partners LLC	7,554	$0.25M	0.0%	-45.5%	0.025%
11/14/2024	Fred Alger Management LLC	17,958	$0.60M	0.0%	N/A	0.059%
11/14/2024	Eventide Asset Management LLC	263,748	$8.84M	0.2%	-53.6%	0.867%
11/14/2024	Verition Fund Management LLC	22,036	$0.74M	0.0%	N/A	0.072%
11/14/2024	Walleye Capital LLC	163,997	$5.49M	0.0%	N/A	0.539%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	32,884	$1.10M	0.0%	+10.9%	0.108%
11/13/2024	BNP Paribas Financial Markets	66,109	$2.22M	0.0%	+6,009.9%	0.217%
11/13/2024	FMR LLC	3,309,175	$110.86M	0.0%	+15.3%	10.875%
11/13/2024	The Manufacturers Life Insurance Company	42,046	$1.41M	0.0%	+66.1%	0.138%
11/13/2024	Fisher Asset Management LLC	61,948	$2.08M	0.0%	-4.7%	0.204%
11/12/2024	Alpha DNA Investment Management LLC	12,160	$0.41M	0.2%	-23.6%	0.040%
11/12/2024	Charles Schwab Investment Management Inc.	160,321	$5.37M	0.0%	+3.2%	0.527%
11/9/2024	Intech Investment Management LLC	6,823	$0.23M	0.0%	N/A	0.025%
11/8/2024	Jennison Associates LLC	264,889	$8.87M	0.0%	N/A	0.966%
11/5/2024	Victory Capital Management Inc.	237,250	$7.95M	0.0%	+677.9%	0.865%
11/5/2024	GSA Capital Partners LLP	17,140	$0.57M	0.0%	N/A	0.062%
10/25/2024	China Universal Asset Management Co. Ltd.	5,808	$0.20M	0.0%	+81.0%	0.021%
10/23/2024	Values First Advisors Inc.	1,451	$49K	0.0%	N/A	0.005%
10/23/2024	Assenagon Asset Management S.A.	475,446	$15.93M	0.0%	+55.1%	1.740%
10/16/2024	nVerses Capital LLC	1,600	$54K	0.0%	+700.0%	0.006%
10/3/2024	Duncan Williams Asset Management LLC	8,425	$0.28M	0.2%	N/A	0.031%
10/3/2024	SG Americas Securities LLC	12,076	$0.41M	0.0%	N/A	0.044%
8/19/2024	Point72 Asset Management L.P.	17,900	$0.45M	0.0%	-97.9%	0.066%
8/16/2024	Algert Global LLC	10,178	$0.26M	0.0%	+11.8%	0.037%
8/16/2024	Frazier Life Sciences Management L.P.	2,165,591	$54.27M	2.5%	+140.7%	7.927%

Data available starting January 2016

See Full Table

AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics. Its products include Rosnilimab, an IgG1 antibody that targets PD-1+ T cells, resulting in their agonism or depletion, broadly impacting pathogenic drivers of autoimmune and inflammatory diseases; and ANB032, a non-depleting antibody that binds to the BTLA checkpoint receptor and inhibits activated T cell proliferation; ANB033, a novel anti-CD122 antagonist antibody that targets the shared common beta subunit of the receptors for IL-15 and IL-2; ANB101, a BDCA2 modulator antibody that specifically targets plasmacytoid dendritic cells (pDCs); and Imsidolimab, an antibody that inhibits the interleukin-36 receptor, which is in the Phase 3 development for the treatment of generalized pustular psoriasis. The company also focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has a collaboration and license agreement with GlaxoSmithKline, Inc. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.

Today's Range

Now: $18.95

$18.61

$19.60

50 Day Range

MA: $17.14

$12.38

$21.22

52 Week Range

Now: $18.95

$12.21

$41.31

Volume

807,790 shs

Average Volume

564,336 shs

Market Capitalization

$581.14 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.02

Who are the company insiders with the largest holdings of AnaptysBio?: AnaptysBio's top insider shareholders include:
Ecor1 Capital, Llc (Director)
Ecor1 Capital, Llc (Major Shareholder)
Daniel Faga (CEO)
Paul F Lizzul (Insider)
Eric J Loumeau (Insider)
Dennis Mulroy (CFO)
Dennis M Fenton (Director)
Hollings Renton (Director)
Eric J Loumeau (Insider)
Learn More about top insider investors at AnaptysBio.
Who are the major institutional investors of AnaptysBio?: AnaptysBio's top institutional investors include:
Vanguard Group Inc. — 6.06%
Fairmount Funds Management LLC — 5.97%
Frazier Life Sciences Management L.P. — 5.17%
Boxer Capital Management LLC — 4.27%
Price T Rowe Associates Inc. MD — 3.04%
First Light Asset Management LLC — 2.86%
Learn More about top institutional investors of AnaptysBio stock.
Which major investors are selling AnaptysBio stock?: In the previous quarter, ANAB stock was sold by these institutional investors:
Frazier Life Sciences Management L.P.
Federated Hermes Inc.
Affinity Asset Advisors LLC
Millennium Management LLC
ADAR1 Capital Management LLC
Bank of America Corp DE
Assenagon Asset Management S.A.
Voloridge Investment Management LLC
During the last year, company insiders that have sold AnaptysBio company stock include:
Ecor1 Capital, Llc (Director)
Ecor1 Capital, Llc (Major Shareholder)
Daniel Faga (CEO)
Paul F Lizzul (Insider)
Eric J Loumeau (Insider)
Learn More investors selling AnaptysBio stock.
Which major investors are buying AnaptysBio stock?: In the last quarter, ANAB stock was purchased by institutional investors including:
Fairmount Funds Management LLC
Boxer Capital Management LLC
Sanofi
Caption Management LLC
Soleus Capital Management L.P.
LMR Partners LLP
Altium Capital Management LLC
Vanguard Group Inc.
In the last year, these company insiders have bought AnaptysBio stock:
Ecor1 Capital, Llc (Director)
Ecor1 Capital, Llc (Major Shareholder)
Learn More investors buying AnaptysBio stock.